Adverse effect due to antibotropic serum

Authors

  • Susana Rodríguez Universidad de la República, Facultad de Medicina, Hospital de Clínicas, Departamento de Toxicología, Asistente
  • Alba Negrin Universidad de la República, Facultad de Medicina, Hospital de Clínicas, Departamento de Toxicología, Ex Asistente. Centro Nacional de Farmacovigilancia, Prof. Adj.
  • Mabel Burger Universidad de la República, Facultad de Medicina, Hospital de Clínicas, Departamento de Toxicología, Prof. Directora. Centro Nacional de Farmacovigilancia, Co-Directora

Keywords:

ANTI-POISONS

Abstract

Ophidian accidents in Uruguay have a variable annual prevalence, from 80 to 100 cases. Most of the reported cases are due to Bothrops gender species (60 to 70 cases a year), and need to be treated with antibothropic serum.
Since 1986 the Comisión Nacional de Ofidismo del Ministerio de Salud Pública has been producing a national protocol on diagnosis, treatment and follow-up. A year earlier, a synthesis of a national anti-ophidian serum commenced.
Since 1999, adverse reactions were seen when national anti-ophidian serum was used. These events were coincident with some difficulties detected on quality controls of the serum and a wider sensitivity about detecting adverse reactions.
A case report where a severe and unfrequent adverse reaction to antibothropic serum is presented.
Etiopathogenesis of the reaction and its correlations to serum are discussed.

References

1) Centro de Información y Asesoramiento Toxicológico. Informe Anual del Centro de Información y Asesoramiento Toxicológico: CIAT, 2000.
2) Dwivedi S, Sheshadri S, D' Souza C. The limit for anti-snake venom administration. Lancet 1989; 2(8663): 622.
3) Bauab FA, Junqueira GR Corradini MC, Silveira PV, Nishioka S de A. Clinical and epidemiological aspects of the "urutu" lance-headed viper (Bothrops alternatus) bite in a brazilian hospital. Trop Med Parasitol 1994; 45(3): 243-5.
4) Haddad LM. North America venoums snake bite. In: Haddad LM, Shannon, MW, Winchester, JF. Clinical Management of Poisoning and Drug Overdose. Saunders, 1998: 333-52.
5) Lie JT. Classification and histopathologic spectrum of Central Nervous System vasculitis. Neurol Clin 1997; 15(4): 805-17.
6) Younger DS, Kass RM. Vasculitis and the nervous system. Neurol Clin 1997; 15(4): 737-51.
7) Weir DM, Stewart J. Inmunología. New York: Churchill Livingstone, 1990: 216-60.
8) Reid HA, Thean PC, Martin WJ. Specific antivenene and prednisone in viper-bite poisoning: controlled trial. Br Med J 1963; 5369: 1378-80.
9) Thomas L, Tyburn B, Ketterle J, Biao T, Mehdaoui H, et al. Prognostic significance of clinical grading of patients envenomed by Bothrops lanceolatus in Martinique. Members of the research Group on Snake Bite in Martinique. Trans R Soc Trop Med Hyg 1998; 92(5): 542-5.
10) Thomas L, Tyburn B, Bucher B, Pecout F, Ketterle J, Rieux D, et al. Prevention of thromboses in human patients with Bothrops lanceolatus envenoming in Martinique: failure of anticoagulants and efficacy of a monospecific antivenom. Research Group on Snake Bites in Martinique. Am J Trop Med Hyg 1995; 52(5): 419-26.
11) Murthy JM, Kishore LT, Naidu KS. Cerebral infarction after envenomation by viper. J Comput Assist Tomogr 1997; 21(1): 35-7. Erratum in: J Comput Assist Tomogr 1997 May-Jun; 21(3): followi.
12) Jurkovich GJ, Luterman A, McCullar K, Ramenofsky ML, Curreri PW. Complications of crotalidae antivenin therapy. J Trauma 1988; 28(7): 1032-7.

Published

2004-12-31

How to Cite

1.
Rodríguez S, Negrin A, Burger M. Adverse effect due to antibotropic serum. Rev. Méd. Urug. [Internet]. 2004 Dec. 31 [cited 2024 Nov. 24];20(3):228-32. Available from: https://revista.rmu.org.uy/index.php/rmu/article/view/910